Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brenda Weigel

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Current Oncology Reports|October 14, 2005
New paradigms for therapy for osteosarcomaRajaram Nagarajan, Denis Clohisy, Brenda Weigel
Current Treatment Options in Oncology|June 15, 2016
Chemotherapy Options for Poor Responders to Neoadjuvant Chemotherapy for Orbital Granulocytic SarcomaNathan Gossai, Rachel Cafferty, Brenda Weigel
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2007
Synergism between etoposide and 17-AAG in leukemia cells: critical roles for Hsp90, FLT3, topoisomerase II, Chk1, and Rad51Qing Yao, Brenda Weigel, John Kersey
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2010
Killing the killer: natural killer cells to treat Ewing's sarcomaYong-Oon Ahn, Brenda Weigel, Michael R Verneris
Sarcoma|April 18, 2020
Prognostic Factors for Development of Subsequent Metastases in Localized Osteosarcoma: A Systematic Review and Identification of Literature GapsPatrick Basile, Emily Greengard, Brenda Weigel, et al.
Pediatric Blood & Cancer|April 21, 2020
Treatment of generalized infantile myofibromatosis with sorafenib and imatinib: A case reportBehzad Bidadi, Andrea Watson, Brenda Weigel, et al.
Pediatric Blood & Cancer|September 5, 2009
Allogeneic hematopoietic cell transplantation (allogeneic HCT) for treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL)Michael J Burke, Qing Cao, Barb Trotz, et al.
Pediatric Blood & Cancer|July 25, 2015
Phase 2 trial of sorafenib in children and young adults with refractory solid tumors: A report from the Children's Oncology GroupAeRang Kim, Brigitte C Widemann, Mark Krailo, et al.
Current Oncology (Toronto, Ont.)|February 23, 2024
The Feasibility and Acceptability of a Data Capture Methodology in Pediatric Cancer Patients Treated with Targeted Agents and ImmunotherapiesKarim Thomas Sadak, Taiwo Opeyemi Aremu, Seah Buttar, et al.
Pediatric Dermatology|January 11, 2022
Successful management of an arteriovenous malformation with trametinib in a patient with capillary-malformation arteriovenous malformation syndrome and cardiac compromiseCynthia L Nicholson, Siobhan Flanagan, Michael Murati, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Current Oncology Reports|October 14, 2005
New paradigms for therapy for osteosarcomaRajaram Nagarajan, Denis Clohisy, Brenda Weigel
Current Treatment Options in Oncology|June 15, 2016
Chemotherapy Options for Poor Responders to Neoadjuvant Chemotherapy for Orbital Granulocytic SarcomaNathan Gossai, Rachel Cafferty, Brenda Weigel
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2007
Synergism between etoposide and 17-AAG in leukemia cells: critical roles for Hsp90, FLT3, topoisomerase II, Chk1, and Rad51Qing Yao, Brenda Weigel, John Kersey
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2010
Killing the killer: natural killer cells to treat Ewing's sarcomaYong-Oon Ahn, Brenda Weigel, Michael R Verneris
Sarcoma|April 18, 2020
Prognostic Factors for Development of Subsequent Metastases in Localized Osteosarcoma: A Systematic Review and Identification of Literature GapsPatrick Basile, Emily Greengard, Brenda Weigel, et al.
Pediatric Blood & Cancer|April 21, 2020
Treatment of generalized infantile myofibromatosis with sorafenib and imatinib: A case reportBehzad Bidadi, Andrea Watson, Brenda Weigel, et al.
Pediatric Blood & Cancer|September 5, 2009
Allogeneic hematopoietic cell transplantation (allogeneic HCT) for treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL)Michael J Burke, Qing Cao, Barb Trotz, et al.
Pediatric Blood & Cancer|July 25, 2015
Phase 2 trial of sorafenib in children and young adults with refractory solid tumors: A report from the Children's Oncology GroupAeRang Kim, Brigitte C Widemann, Mark Krailo, et al.
Current Oncology (Toronto, Ont.)|February 23, 2024
The Feasibility and Acceptability of a Data Capture Methodology in Pediatric Cancer Patients Treated with Targeted Agents and ImmunotherapiesKarim Thomas Sadak, Taiwo Opeyemi Aremu, Seah Buttar, et al.
Pediatric Dermatology|January 11, 2022
Successful management of an arteriovenous malformation with trametinib in a patient with capillary-malformation arteriovenous malformation syndrome and cardiac compromiseCynthia L Nicholson, Siobhan Flanagan, Michael Murati, et al.
Pageof 5